nadp has been researched along with Cerebrovascular Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, L; Chen, J; Chen, Z; Ding, Y; Feng, X; Li, M; Qin, YY; Qin, ZH; Sheng, R; Zhang, D | 1 |
Wang, X; Xu, Y; Zhao, G; Zhao, Y | 1 |
Duckworth, WC | 1 |
1 review(s) available for nadp and Cerebrovascular Disorders
Article | Year |
---|---|
Hyperglycemia and cardiovascular disease.
Topics: Blood Glucose; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Diabetic Angiopathies; Glycation End Products, Advanced; Humans; Hyperglycemia; NADP; Oxidative Stress; Postprandial Period; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk Factors | 2001 |
2 other study(ies) available for nadp and Cerebrovascular Disorders
Article | Year |
---|---|
G6PD plays a neuroprotective role in brain ischemia through promoting pentose phosphate pathway.
Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Glucose; Glucosephosphate Dehydrogenase; Glutathione; Male; Mice; Mice, Inbred ICR; Middle Cerebral Artery; NADP; Neurons; Oxidative Stress; Oxygen; Pentose Phosphate Pathway; Primary Cell Culture; Reperfusion Injury; RNA, Messenger; RNA, Small Interfering; Stroke | 2017 |
Knockdown of glucose-6-phosphate dehydrogenase (G6PD) following cerebral ischemic reperfusion: the pros and cons.
Topics: Animals; Blotting, Western; CA1 Region, Hippocampal; Cell Death; Cerebrovascular Disorders; DNA Damage; Glucosephosphate Dehydrogenase; Glutathione; Heart Arrest; Immunohistochemistry; Male; NADP; NADPH Oxidases; Nerve Tissue Proteins; Neurons; Oligodeoxyribonucleotides, Antisense; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxides | 2012 |